Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Verheij

Showing results (101-110 of 182) with videos related to

Pageof 19
Sort By:
Annals of Surgical Oncology|August 29, 2014
Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an r1 resection? Results from a dutch cohort studyJurriën Stiekema, Anouk K Trip, Edwin P M Jansen, et al.
Annals of Surgical Oncology|November 13, 2012
Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancerJohan L Dikken, Raymond E Baser, Mithat Gonen, et al.
Seminars in Radiation Oncology|June 18, 2023
[18F]FDG-PET-Based Personalized Radiotherapy Dose PrescriptionJohannes H A M Kaanders, Johan Bussink, Erik H J G Aarntzen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 22, 2016
Analysis of GTV reduction during radiotherapy for oropharyngeal cancer: Implications for adaptive radiotherapyOlga Hamming-Vrieze, Simon R van Kranen, Wilma D Heemsbergen, et al.
EJNMMI Physics|June 4, 2020
A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapyDaphne M V Huizing, Steffie M B Peters, Michelle W J Versleijen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2015
Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and PatientsMonique C de Jong, Jelle J Ten Hoeve, Reidar Grénman, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 24, 2019
Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiationJoris B W Elbers, Lars I Veldhuis, Patrick A Bhairosing, et al.
Acta Oncologica (Stockholm, Sweden)|February 3, 2022
Age-specific incidence, treatment, and survival trends in esophageal cancer: a Dutch population-based cohort studyAli Al-Kaabi, Nikolaj S Baranov, Rachel S van der Post, et al.
Radiation Oncology (London, England)|July 31, 2015
Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancerShuraila F Zerp, T Rianne Stoter, Frank J P Hoebers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 15, 2013
Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigatingMichel M van den Heuvel, Wilma Uyterlinde, Andrew D Vincent, et al.
Pageof 19

Showing results (101-110 of 182) with videos related to

Sort By:
Pageof 19
Annals of Surgical Oncology|August 29, 2014
Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an r1 resection? Results from a dutch cohort studyJurriën Stiekema, Anouk K Trip, Edwin P M Jansen, et al.
Annals of Surgical Oncology|November 13, 2012
Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancerJohan L Dikken, Raymond E Baser, Mithat Gonen, et al.
Seminars in Radiation Oncology|June 18, 2023
[18F]FDG-PET-Based Personalized Radiotherapy Dose PrescriptionJohannes H A M Kaanders, Johan Bussink, Erik H J G Aarntzen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 22, 2016
Analysis of GTV reduction during radiotherapy for oropharyngeal cancer: Implications for adaptive radiotherapyOlga Hamming-Vrieze, Simon R van Kranen, Wilma D Heemsbergen, et al.
EJNMMI Physics|June 4, 2020
A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapyDaphne M V Huizing, Steffie M B Peters, Michelle W J Versleijen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2015
Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and PatientsMonique C de Jong, Jelle J Ten Hoeve, Reidar Grénman, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 24, 2019
Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiationJoris B W Elbers, Lars I Veldhuis, Patrick A Bhairosing, et al.
Acta Oncologica (Stockholm, Sweden)|February 3, 2022
Age-specific incidence, treatment, and survival trends in esophageal cancer: a Dutch population-based cohort studyAli Al-Kaabi, Nikolaj S Baranov, Rachel S van der Post, et al.
Radiation Oncology (London, England)|July 31, 2015
Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancerShuraila F Zerp, T Rianne Stoter, Frank J P Hoebers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 15, 2013
Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigatingMichel M van den Heuvel, Wilma Uyterlinde, Andrew D Vincent, et al.
Pageof 19